Trupanion Inc (NYSE:TRUP) is scheduled to post its quarterly earnings results after the market closes on Monday, October 30th. Analysts expect Trupanion to post earnings of ($0.03) per share for the quarter.

Trupanion (NYSE:TRUP) last announced its earnings results on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.01. The firm had revenue of $58.30 million for the quarter, compared to analysts’ expectations of $57.58 million. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The business’s revenue was up 27.3% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.03) EPS. On average, analysts expect Trupanion to post $-0.09 EPS for the current fiscal year and $0.03 EPS for the next fiscal year.

Shares of Trupanion Inc (NYSE:TRUP) opened at 28.50 on Monday. The stock’s market capitalization is $854.86 million. The stock’s 50 day moving average is $25.23 and its 200 day moving average is $21.32. Trupanion Inc has a 12 month low of $13.71 and a 12 month high of $28.96.

In other Trupanion news, insider Darryl Rawlings sold 3,500 shares of Trupanion stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $21.13, for a total transaction of $73,955.00. Following the transaction, the insider now directly owns 1,449,505 shares of the company’s stock, valued at $30,628,040.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Howard E. Rubin sold 100,000 shares of Trupanion stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $25.90, for a total transaction of $2,590,000.00. The disclosure for this sale can be found here. Insiders have sold 147,052 shares of company stock worth $3,662,969 over the last ninety days.

Several research firms have recently weighed in on TRUP. Zacks Investment Research downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. BidaskClub raised shares of Trupanion from a “hold” rating to a “buy” rating in a research note on Friday, October 13th. Canaccord Genuity raised their price target on shares of Trupanion from $28.00 to $29.00 and gave the stock a “buy” rating in a research note on Wednesday, August 2nd. Cowen and Company reissued an “outperform” rating and issued a $28.00 price target (up from $19.00) on shares of Trupanion in a research note on Wednesday, August 2nd. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $24.00 price target (up from $18.00) on shares of Trupanion in a research note on Wednesday, August 2nd. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Trupanion has a consensus rating of “Buy” and a consensus price target of $26.50.

TRADEMARK VIOLATION NOTICE: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/23/trupanion-inc-trup-set-to-announce-earnings-on-monday.html.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Earnings History for Trupanion (NYSE:TRUP)

Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.